• Demand for Functional Mushrooms Experiencing CAGR of Over 10 Percent
• Market Projected to Increase from $23 billion in 2020 to $34 billion by 2024
• 61% of the Americans Say Healthfulness Significantly Impacts Their Food Purchases
• Rritual Superfoods Offering Functional Products Based on Chaga, Lion’s Mane and Reishi Mushrooms
• Company Led by Stellar Consumer Packaged Goods (“CPG”) Executive Cast

Functional foods are fast-rising fare for a growing number of Americans. It’s the same on the world stage, where similar forces are in play. As a result, the functional foods market is projected to continue its current 7.9% CAGR until the year 2025. One sector of the market — functional mushrooms — is growing even faster. Demand for functional mushroom is forecast to increase at a CAGR of more than 10%, from $23 billion in 2020 to $34 billion by 2024. These developments augur well for innovative start-up Rritual Superfoods. The company has developed a suite of health-enhancing “functional” products based on various types of mushrooms. With marketing and distribution initiatives spearheaded by an experienced team of consumer packaged-good (“CPG”) executives, Rritual plans to quickly establish a dominant presence in the fast-developing functional foods market. Much better informed and with higher incomes, 21st-century food shoppers are a great deal more selective than previous generations. In pursuit of a diet that supports wellness, they are shifting their purchases towards functional foods. Paradoxically, the fast food industry, with its overly processed products packed with artificial ingredients, might be partly responsible. Growing awareness of the ills brought on by their menus is spurring the food shopper of today to look for products that not only offer convenience but are conducive to good health. The 2018 Food & Health Survey conducted by the International Food Information Council Foundation found that “61% of the American population say healthfulness has a significant impact on their food and beverage purchases” (https://ibn.fm/UyZQA). Consumers don’t just want food to taste good, they want it to have “function,” where the function is some improvement in physiological or psychological well-being. As a separate consumer sector, functional foods have taken off in the Far East as well. Its origins may be traced back to 1991, when Japan’s Ministry of Health began designating some foods as “foods for specified health uses” (“FOSHU”) (https://ibn.fm/1P3SW). However, functional foods, under the label of “fortified foods,” have been available for decades. In the United States, iodine was first added to salt in 1924 in an attempt to alleviate incidences of goiter. And in the early 1930s, cow’s milk began to be fortified with vitamin D to combat rickets, which causes poor bone development and deformities in children. Functional mushrooms predate even these developments. They have been used as health aids for over two millennia. To name just a few, there’s turkey tail, an immune booster; chaga, an immune booster and anti-inflammatory; lion’s mane, a booster for the brain and immune system;  reishi, another immune booster, which also helps to cope with anxiety; and Cordyceps, an energy booster. Ranked as a top-10 food trend by Whole Foods, functional mushrooms are typically consumed in a dry, powdered form. They can be combined with adaptogen herbs, which help the body handle stress, for unique benefits. With a long shelf life when correctly processed and packaged., functional mushrooms are set to transform the functional food industry. Since the industry is in an early stage of development, no market leader has emerged. This presents opportunity the Rritual management are poised to seize. The team is headed by CEO David Kerbel, who brings more than 30 years of experience at a senior level in retail, brokerage and CPG. David was an early Senior Vice President of Celsius Holdings, which currently trades on the Nasdaq (CELH). Warren Spence is chief operating officer. Spence has occupied senior positions at Red Bull and Olivieri during his 25-year career in the food and beverage industry. Rounding out the lineup of top CPG operatives is VP of USA sales Sarton Molnar-Fenton, a former executive of Danone and Nestlé. For more information, visit the company’s website at https://investors.wearerritual.com. Mental Fitness Is a Daily Ritual NOTE TO INVESTORS: The latest news and updates relating to Rritual are available in the company’s newsroom at http://ibn.fm/Rritual

• USI is a brokerage and consulting firm with over 7,500 professional and nationally networked brokers that will expand the InsuraGuest brand exposure
• The global insurtech market is expected to reach $10.14 billion by 2025 with a CAGR of 10.8% – up from $5.48 billion in 2019
• InsuraGuest is currently ahead of its growth model’s expectations
• The proprietary insurtech platform can integrate with over 70 property management systems for easy implementation

Innovative insurtech provider InsuraGuest Technologies (TSX.V: ISGI), via wholly-owned subsidiary InsuraGuest Inc., recently signed an Agent Producer Agreement with USI Insurance Services (“USI”), a leading United States insurance brokerage and consulting firm. Under the agreement, USI will distribute InsuraGuest’s innovative Hospitality Liability coverages through its network of more than 7,500 professional brokers nationwide (https://ibn.fm/CsfBt). This agreement with USI continues a series of partnerships that InsuraGuest has been signing lately to expand the reach of its insurtech platform and insurance services. “InsuraGuest continues to attract and execute exciting relationships with nationally recognized leaders in the insurance industry,” CEO and Chairman Douglas Anderson said. “Our sales and outreach program, paired with our expansive broker networks, allow us to expand our customer base and grow our brand recognition more quickly than our original growth models indicated.” According to the CEO, this growth avenue will not only increase sales dramatically and provide true nationwide coverage, but it will increase shareholder value as a result. These partnerships can help InsuraGuest to further cement its leading position on the fast-growing insurtech martket. With technology touching almost every industry worldwide, the insurance industry has been no exception. Valued at $5.48 billion in 2019, the global insurtech sector is expected to reach $10.14 billion by 2025, with a CAGR of 10.8% during the forecast period of 2019-2025 (https://ibn.fm/3MqKV). This growth offers multiple opportunities to InsuraGuest, a company committed to harnessing the power of technology to reinvent the insurance industry. With a proprietary software platform that delivers digital insurance to multiple sectors across various industries, the company aims to revolutionize the way insurance is delivered based on the idea that insurance should be bought and not sold. InsuraGuest’s proprietary insurtech platform and liability coverages provide a viable solution to the high frequency of claims that hotel and vacation rental operators are facing and that are frequently applied to the general liability policy, resulting in higher risk exposure and higher premium prices for the property owners. InsuraGuest’s solution transfers the risk from the hotel and vacation rental operators by having guests pay for the coverage at a nomrinal fee per night. Then, all small claims are paid by InsuraGuest, thus keeping them off the property owner’s general liability policy. InsuraGuest Hospitality Liability covers incidentals such as accidents, in-room property damage, accidental medical, death, or dismemberment, or theft claims, which can be filed through the Hospitality Liability coverages instead of the general liability coverage. In addition to reduced risk and lower premiums, the benefits of incorporating the insurtech platform include affordable supplemental insurance options at affordable pricing, improved guest experiences, and prompt compensation. In the last decade, approximately $16.5 billion has been invested in insurtech. The pressure for change and innovation within the insurance market continues to increase. InsuraGuest has been riding the wave of technological insurance innovation within the digital sector but has been expanding outward, offering insurtech options to a wider audience and creating additional revenue streams. For more information, visit the company’s website at www.InsuraGuest.com. NOTE TO INVESTORS: The latest news and updates relating to ISGI are available in the company’s newsroom at http://ibn.fm/ISGI

• Josemaria Resource’s flagship copper-gold-silver mine is expected to generate an average annual production of 136,000 tonnes of copper, 231,000 ounces of gold and 1,164,000 ounces of silver over its 19-year life
• Copper is known for its varied industrial uses, particularly within renewable power generation sector
• A single wind turbine is said to utilize up to 4.7 tonnes of copper, while each MW of solar power energy employs over 5.5 tonnes of copper during installation
• Research suggests that global copper production will have to rise by 3-6% per annum over next ten years for countries to meet their targets under remits of Paris Agreement

Josemaria Resources (TSX: JOSE) (OTCQB: JOSMF), a Canadian natural resources company, has recently published a NI 43-101 compliant feasibility study for its flagship project, the wholly owned Josemaria Project located in Argentina’s San Juan Province (https://ibn.fm/rcN78). The study revealed that the mine was anticipated to generate an average annual production of 136,000 tonnes of copper, 231,000 ounces of gold and 1,164,000 ounces of silver over its 19-year life span. These figures paint a bullish picture – the mine’s copper production alone would be equivalent to nearly 1% of annual global supply—but an analysis into the dynamics underpinning current copper prices presents an even rosier outlook. Copper is often said to be one of the most versatile metals, with uses varying from building tools to biology – in fact, humans are said to need 1.2 milligrams of copper daily to help enzymes transfer energy inside the body’s cells (https://ibn.fm/rNKeN). Most notably, due to its ductility and electrical and thermal conductivity, copper is most often utilized in the production of electrical conductors, switches, transformers and wiring (https://ibn.fm/lQw4g). The global shift toward the electrification movement can be best visualized in The Paris Agreement—a global climate accord which has attracted 194 countries and the European Union, altogether representing approximately 79% of global greenhouse gas emissions, with the intent of capping the global temperature rise this century (https://ibn.fm/ax2mT). In practice, the agreement has led to a surge in investment in electric vehicles and renewable energy sources, with China announcing on November 23, 2020 its plan to budget $910 million for renewable energy subsidies in 2021. Copper has established itself as perhaps the most critical metal within the renewable energy complex. The generation of clean energy from solar and wind sources utilizes copper at a rate of four to six times greater relative to its usage within fossil fuel-powered electricity generation. For instance, an average 3 megawatt (“MW”) wind turbine is said to contain up to 4.7 tons of copper, with 53% of that figure being used in the form of cable and wiring, 24% contained within the wind turbine and a further 19% within the turbine transformer (https://ibn.fm/J96aZ). Despite the industrial slowdown caused by the COVID-19 pandemic, global offshore wind investment touched a new high of $34.9 billion in the first half of 2020 – a figure which quadrupled the investment seen in the first half of 2019 and which sits well above the total for last year as a whole (https://ibn.fm/kptfC). Solar energy farms have also been avid users of the metal, with a study finding that each MW of solar power utilized an average 5.5 tons of copper in the form of heat exchangers, wiring and cabling. In fact, a study carried out from Navigant Research forecast that over 1.9 billion pounds of copper would be consumed between 2018 and 2027 in North America alone, to build an estimated 262 GW of planned solar installations (https://ibn.fm/Ck9fO). Meanwhile, new energy vehicles are not far behind in copper consumption. Lithium ion batteries, which power everything from mobile handsets to Tesla vehicles, contain an estimated 440 pounds of copper per MW. With Deloitte recently suggesting that battery-powered electric vehicles would account for approximately 32 percent of the total market share for new car sales by 2030 (https://ibn.fm/gVOcW), the forecasted demand for copper is clearly set to increase exponentially in coming years. Copper has long been heralded for its close correlation to global economic growth – recent trends suggest it is also set to be a key beneficiary from the global shift towards renewable energy sources. With copper demand set to continue its stunning growth patterns in coming years – a study by Bernstein Research suggested that global copper production would have to rise by between 3 percent and 6 percent per annum to meet expected demand (https://ibn.fm/ESgB2) – Josemaria Resources may find that it is involved in the right metal, at exactly the right time. For more information, visit the company’s website at www.JosemariaResources.com. NOTE TO INVESTORS: The latest news and updates relating to JOSMF are available in the company’s newsroom at https://ibn.fm/JOSMF

• NETE results include year-over-year increases in revenue and transaction volume
• 45% of NETE clients in restaurant business, management expects rebound once states reopen
• NETE plans to divest payments processing model to enter EV industry through reverse-merger with privately-held Mullen Technologies Inc.

Net Element (NASDAQ: NETE), a global financial technology and payments processing company, recently posted its Q3 2020 results showing improved revenues despite continued shutdowns in NY and California. The value-added solutions group supports electronic payments acceptance in an omni-channel environment that spans point-of-sale, e-commerce applications and mobile devices for small to medium enterprises in the U.S. and selected emerging markets. Business closures due to COVID-19 have affected NETE revenues negatively, particularly for the restaurant industry that comprises approximately 45% of its customer base. With most of the business coming from the southern states, NETE management believes that card processing volumes for the company could rebound sharply if their customers in New York and California could open up again. Despite the negative outlook and overall sinking economy, company revenues improved in Q3 2020, coming in at $16.7 million from $13.7 million in Q2 2020 (https://ibn.fm/S1d2d). Other highlights from their Q3 results include a year-over-year increase in total transaction volume from $956.2 million to $953.7 million and a year-over-year increase in their North American Transaction Solutions segment to $16.07 million from $15.9 million (https://ibn.fm/od2oj). The company reported a net loss to common stockholders of approximately $0.52 per share or a total net loss of $2.3 million – almost twice the $1.0 million net loss or $0.24 per share loss for the same period in 2019. The $1.3 million net loss increase is primarily attributed to an increase in non-cash compensation of approximately $1.1 million and an increase in bad debt expense amounting to approximately $200,000. Gross margin for the quarter was $2.2 million or 13.0% of net revenues, down from $2.7 million or 16.3% for the same period in 2019, attributed to the increased competitive pressure in the industry. Year-over-year operating expenses increased to $4.1 million from $3.6 million while salaries, benefits, taxes and contractor payments decreased by approximately $0.4 million due to staffing reductions connected to COVID-19. Earlier this year, NETE announced plans to divest itself of its payments processing services in order to enter the electric vehicle industry through a reverse merger with Mullen Technologies. Following the requisite approvals, the transaction will allow the stakeholders of privately-held Mullen to gain a majority of the new stock while accelerating the process of taking the new company public. NETE continues to work diligently on the transaction while Mullen completes its audit and S-4 document with expectations to have it filed by the end of the year. “We continue working diligently in an effort to finalize the Mullen merger for the benefit of our shareholders,” said Net Element Executive Chairman Oleg Firer. Formerly ranked as one of North America’s fastest growing companies on Deloitte’s Technology Fast 500(TM) in 2017 and 2018, NETE offers 100-plus payment solutions in an omni-channel environment for small to medium enterprises. Following the approval of its reverse merger with California-based Mullen Technologies, the company plans to divest its payments-as-a-service business model and enter the electric vehicle industry. For more information, visit the company’s website at www.NetElement.com.

• COVID-19, the election, and preference shift towards growth-oriented stocks causing unprecedented stock market volatility
• SRAX’s Sequire SaaS platform unlocks big data investor insights for public companies
• Sequire’s user base grown to over one million investors, traders across 125 companies and partners
• Sequire’s Q3 2020 performance includes over $6.7 million in bookings and 37% increase in subscriptions

The stock market is currently going through a phase of unprecedented volatility caused primarily by political and societal issues, projected to continue well into 2021. As a proactive response, some public companies are choosing to gain clarity about their investor activity through Sequire, a SaaS platform created by SRAX (NASDAQ: SRAX) that unlocks data and insights through warrant tracking, survey creation, events, roadshows and customer relationship/resource management (“CRM”). According to a recent BTIG report (https://ibn.fm/QXqZ0), issues with COVID-19, the United States presidential election and a general market shift towards growth-oriented stocks are the three major transitory events causing extreme volatility in the markets. “We’re living through three transitions which, in a period of elevated volatility, are reminders that the path to the long term is a series of short terms — often gut-wrenching, both down and up,” wrote strategists Julian Emanuel and Michael Chu in the BTIG report. Among other factors connected to the economic downturn, volatile market conditions have added to the toll taken on public companies. Besides poor performance across almost every industry, the situation has been made more challenging by extra pressure from stakeholders on management to keep driving share prices upward. To that end, Sequire has the potential to add significant value to marketing efforts by unlocking the power of data, engaging current investors and attracting new capital through marketing campaigns. Since its creation in 2019, the platform’s user base has grown rapidly to over one million investors and traders across 125 companies and partners. Accordingly, Sequire’s performance in Q3 2020 was stellar with over $6.7 million in bookings, its first positive quarter EBITDA, and a 37% increase in subscriptions. SRAX’s overall performance is in line with the success of the platform, with 161% year-over-year and 124% quarter-over-quarter revenue growth. “As the Sequire platform continues to grow and adapt to customer needs, we are seeing a tremendous increase in our recurring revenue stream,” said SRAX Founder and CEO Chris Miglino. “Sequire is changing the way public issuers interact with and engage their investors, and it shows. We are pleased to report our first quarter of positive EBITDA from our Sequire segment” (https://ibn.fm/buUFN). SRAX is a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its premier investor intelligence and communications platform. Through Sequire, companies can track investor behaviors and identify trends for use in campaigns to engage current and potential investors across marketing channels. For more information, visit the company’s website at www.SRAX.com NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

• Alternatives to potato sprout inhibition in critical need as U.S. moves towards eliminating CIPC
• CIPC, leading agrochemical product used for sprout suppression, was banned by EU in October
• MGRO’s patent focused on controlling vegetable, potato sprouting without harmful synthetic chemicals

MustGrow Biologics (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) has been granted an exclusive patent licensing from the University of Idaho in Moscow, Idaho (https://ibn.fm/vW2Ag). The patent is in connection with a natural biopesticide mustard-based treatment of stored produce and other foods. The ability the treatment may have for sprout suppression of potatoes is gaining particular interest in Idaho, which is the largest producer of potatoes in the country. “Alternatives to potato sprout inhibition are in critical need as the U.S. moves towards eliminating CIPC,” said MustGrow’s recently appointed scientific advisor, Dr. Matthew J. Morra, a leading world expert on value-added products derived from oilseeds. “Mustard-derived biopesticides rely on a natural sprout inhibitor that meets the needs of the potato industry without the negative human health consequences of current synthetic sprout inhibitors.” CIPC, or chlorpropham, is the leading agrochemical product used for sprout suppression, which is a critical element of potato storage. However, the chemical was banned by the European Union in October. Morra, a professor emeritus of soil biochemisty at the University of Idaho, is one of three inventors listed on MustGrow’s new patent. Potential for the patent is promising, with the current annual European sprout suppression market estimated at $64 million; globally the market is forecast to top $100 million. The recent ban could have a significant impact on that market, as potato farmers will be forced to refrigerate their produce. That alone could increase costs by an estimated $150 million each year in the EU, an increase most consider unsustainable. Growers are eager to identify alternative solutions. As a result, MustGrow’s exclusive licensing from the University of Idaho, which was granted earlier this year, has taken on added importance. Titled “Mustard Meal to Inhibit Sprouting,” the patent makes matter and method claims to use the mustard plant’s active ingredient, allyl isothiocyanate, in its efforts to control vegetable and potato sprouting without the use of harmful synthetic chemicals. MustGrow is working on providing options for the food-storage industry, particularly potatoes and grains, that combine its expertise in mustard-derived AITC with its newly secured patent. In this effort, the company has identified potential partners in relevant global regions based on food product characteristics and economics. MustGrow is an agriculture biotech company focused on providing natural, science-based biological solutions for high-value crops, including fruits and vegetables. MustGrow has designed and owns a U.S., EPA-approved natural solution that uses the mustard seed’s natural defense mechanism to protect plants from pests and diseases. More than 110 independent tests have been completed validating MustGrow’s safe and effective signature products. The product, in granule format, is EPA-approved across all key U.S. states and by Health Canada’s Pest Management Regulatory Agency (“PMRA”) as a biopesticide for high-value crops such as fruit and vegetables. MustGrow has now concentrated a liquid format, called TerraMG, which, with regulatory approval, could be applied through standard drip or spray equipment, improving functionality and performance features. For more information, visit the company’s website at www.MustGrow.ca. NOTE TO INVESTORS: The latest news and updates relating to MGROF are available in the company’s newsroom at https://ibn.fm/MGROF

• Livestreaming platform allows artists to create exclusive artist-content channels, live-event streaming and promotional support
• New November artist sign-ups bring almost 500,000 fans, followers with them
• FDBL CEO notes “significant achievements at almost every turn as we build on the initial wave of response to the Fan Pass offering”

Friendable (OTC: FDBL) has announced that its proprietary live-streaming platform, Fan Pass, has reached a significant milestone: 50 exclusive artist channels are now live across the different genres available, adding to the overall total of 70 live artist channels (https://ibn.fm/4actX). New November artist sign-ups bring almost 500,000 fans and followers with them.

FDBL’s Fan Pass platform is designed to help artists engage with their fans around the world — and earn revenue while doing so. The livestreaming platform supports all different levels of artists, allowing them to create exclusive artist-content channels, live-event streaming, promotional support, fan subscriptions and custom merchandise designs, all of which can serve as revenue streams for each artist. Once artists sign up on the Fan Pass platform and complete the onboarding process, including approving channel assets, graphics, content and imagery, they can schedule live performances, offer merchandise and invite fans to engage with them.

The recent milestone — 50 artists able to successfully complete onboarding since Fan Pass’s July launch — indicates the process has been streamlined and enhanced, providing greater opportunity for the number of artists and volume of content to increase.

“There have been significant achievements at almost every turn as we build on the initial wave of response to the Fan Pass offering, and adding artists who have a significant base of fans and followers is always something we are keen to do,” said Friendable CEO Robert A. Rositano Jr. “The latest round of sign-ups has brought three such artists to the forefront, and our team is excited to launch their channels so we can test their reach and engagement in this regard. The reach of each of these three artists varies, but as you will recognize straight away, this is a big opportunity for our platform to reach their fan bases.”

The three artists Rositano referenced are Hot Boy Turk, Leeky Bandz and Bigga$tate. Hot Boy Turk  brings the largest fan following, with 372,000 fans on a verified Instagram account and 10,400 YouTube subscribers. Leeky Bandz has 44,300 Instagram followers through a verified IG account, 38,702 monthly listeners on Spotify, 17,500 subscribers on YouTube and collabs with artists such as Gunna and YoungBoy Never Broke Again. Bigga$tate has 21,500 Instagram followers and 6,607 monthly listeners on Spotify; his most recent music video received more than 40,000 views.

Friendable is a mobile technology and marketing company focused on connecting and engaging users through its proprietary mobile and desktop applications. With Fan Pass, artists can offer exclusive content channels to their fans, who can simply use their smartphones to gain access to their favorite artists as well as all-access passes that provide access to all artists on the platform. Additionally, the Fan Pass team will deploy social broadcasters to capture exclusive VIP experiences, interviews and behind-the-scenes content featuring their favorite artists.

For more information, visit the company’s website at www.Friendable.com.

NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

• Recent report estimates EEG equipment market will grow at 4.5% CAGR reaching $1.99 billion by 2026
• Driving forces include aging population, technological advances, increased use in neonatal intensive care units
• BRSF well-placed to capitalize on market’s robust growth

A recent report published by Allied Market Research estimates that the global electroencephalography (“EEG”) equipment market was $1.4 billion in 2018 and is expected to reach $1.99 billion by 2026, growing at a CAGR of 4.5% from 2019 to 2026 (https://ibn.fm/Jmxjq). As a commercial-stage, healthcare company dedicated to developing innovative medical devices in the neurological diagnostics space, Brain Scientific (OTCQB: BRSF) seems well placed to capitalize on the growing EEG equipment market.

The key driving forces behind the market growth include factors such as the aging population, which leads to the increase in demand for brain diagnostics due to neurological diseases, as well as the increase in adoption of EEG equipment in surgery centers coupled with technological advancements in this field. In addition, the rise in the incidence of neurological disorders such as epilepsy and Alzheimer’s disease also contributes to the increase in demand for EEG equipment.

The Allied Market report cites the disease diagnosis segment as the largest EEG equipment market segment measured by the market share and also the fastest-growing one due to the surge in prevalence of neurological disorders across the globe. The increase in adoption of EEGs in neonatal intensive care units is expected to be another major driving force behind the rapid growth of the diagnostic segment.

The demand for neurological diagnostic services is growing rapidly. Still, the supply of trained neurologists remains limited, resulting in significantly limited access to neurological care globally including in developed countries. This is where Brain Scientific’s solutions shine. BRSF has developed two FDA-cleared products: NeuroCap, a disposable, pre-gelled EEG headset that can be applied easily and quickly, and NeuroEEG, a lightweight, wireless, portable EEG amplifier for high-quality EEG tests.

Apart from designing solutions that address the needs of patients with neurodegenerative diseases such as Alzheimer’s, Brain Scientific is developing product line extensions to address the growing pediatric market, which the report also cites as one of the key factors contributing to the EEG equipment market growth. As a company dedicated to developing breakthrough EEG technology to solve the shortage in neurological care, Brain Scientific seems well positioned within the EEG equipment market to benefit from the growing unmet need for the brain diagnostics market.

For more information, visit the company’s website at www.BrainScientific.com.

NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at https://ibn.fm/BRSF

• PowerTap Hydrogen Fueling Corp. (“PowerTap”) engages services of NASA-based hydrogen engineering firm, Cryotek
• Hydrogen fuel cell vehicle market forecasted for CAGR of 66.9% from 2019 to 2026 and projected to reach $42 billion by 2026, according to Allied Market Research (https://ibn.fm/ejitO)
• PowerTap plans to install an initial 500 hydrogen filling stations in California and an additional 500 hydrogen filling stations over next three to five years in other parts of the USA.
• Clean energy expert Greg Nuttall appointed to the PowerTap advisory board.

The announcement by Clean Power Capital (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF) that its investee company, PowerTap, has engaged NASA-based hydrogen engineering firm, Cryotek, as an engineering design partner will give an added fillip to the value of Clean Power’S investment in the fast-growing hydrogen fuel-cell vehicle market. Clean Power Capital is an investment holding company with investments in the health industry and renewable energy industry, has recently increased its focus on opportunities in the renewable energy industry, including fuel-cell technologies. The collaboration between PowerTap and Cryotek will advance PowerTap’s efforts to commercialize its patented hydrogen filling technology, and therefore increase the value of Clean Power’s investment in fuel-cell technologies and PowerTap.

PowerTap is aiming to deploy hydrogen fueling units at existing truck stops and gas stations across the USA, with an initial deployment of up to 500 units in California. Including the initial expansion of up to 500 stations in California, PowerTap has set a target of up to 1,000 stations stations in total, within the next three to five years throughout the USA. To bolster its expertise in this area, PowerTap has appointed Greg Nuttall, one of the clean energy sector’s most foremost figures, to its advisory board. With rapid growth projected for the adoption of hydrogen fuel-cell power systems, PowerTap appears to have hitched its wagon to a star.

The hydrogen fuel cell vehicle market is forecasted to undergo a CAGR of 66.9% from 2019 to 2026, reaching $42 billion by the end of the forecast period (https://ibn.fm/Z2czd). Rising concern over the environmental impact of fossil fuels and an increase in government’s support of hydrogen fuel-cell infrastructure are two of the factors fueling industry growth.

PowerTap has engaged the services of Cryotek, a company focused on developing cryogenic solutions for NASA (USA National Aeronautics and Space Administration) and the U.S. Department of Energy (https://ibn.fm/qTffv). Cryotek is also working to add liquid hydrogen to the list of energy sources for vehicles in the future. As a result, the company has developed proficiency in the design of smaller hydrogen steam methane reformation (“SMR”) units.

Cryotek’s mandate includes the following:

• Next-generation PowerTap Onsite Steam Methane Reformer (“SMR”) solution capable of producing 1,000kg+ per day
• Gaseous and liquid hydrogen storage solutions
• CO2 capture solutions
• Advanced hydrogen dispensing unit
• Artist rendition of proposed final hydrogen filling station.

SMR units combine methane and steam at high pressures to produce hydrogen. The hydrogen produced in the process, known as natural gas reforming, can power fuel cell electric vehicles (FCEVs), cutting total greenhouse gas emissions in half and reducing by over 90% the amount of gasoline in use today. The hydrogen filling units will be capable of producing more than 1,000 kilograms of hydrogen on a daily basis.

As the commercialization of the PowerTap technology picks up, PowerTap has asked Nuttall to sit on its advisory board (https://ibn.fm/nIWgq). Nuttall is an experienced clean-energy executive. He founded the world’s first waste-to-fuel company, Woodland Biofuel, which has received funding from the Canadian federal government as well as private investors. Nuttall was formerly a merchant banker. He is a corporate finance lawyer who obtained a master of international laws degree from Cambridge University.

For more information, visit the company’s website at www.CleanPower.Capital.

NOTE TO INVESTORS: The latest news and updates relating to MOTNF are available in the company’s newsroom at https://ibn.fm/MOTNF

• In July 2020, CannAssist International became among the first U.S.-based CBD companies to have its securities listed for trading onto a U.S. public capital market
• Xceptor Labs uses proprietary technology to create CBD products that it believes have better absorption than currently marketed oil-based products
• The company currently has five creams that utilize ingredients with National Drug Codes that are registered with the FDA
• The company’s Xceptol line of topical pain cream products, formulated using its proprietary CiBiDinol technology, was launched in September 2020. The company has since added capsules and, very soon, tinctures and pet drops
• The company’s marketing structure for Xceptol includes social media campaigns featuring celebrities and former athletes represented through Freedman Sports Promotional Relations
• CannAssist is currently targeting North America, Central America, South America, South Africa, the EU, the UK and the Philippines as viable product markets
• Strategic partnerships have already collaborated in sourcing, manufacturing, processing, laboratory, distribution, public relations and legal representation
• The global market for cannabidiol is expanding steadily and is forecast to reach $23.6 billion in 2025

CannAssist International (OTCQB: CNSC), owner of Xceptor Labs, is a biotechnological pharmaceutical and wellness company marketing the Xceptol consumer brand. CannAssist, a Delaware corporation, was established in May 2017 and is headquartered in San Diego County, California. 2018 Farm Bill and CBD Market Size Signed into law in December 2018, the Agriculture Improvement Act of 2018 (2018 Farm Bill) removed hemp from its classification as a Schedule I drug under the Controlled Substances Act of 1970. There are over 100 known cannabinoids within the hemp plant. The two most commonly utilized cannabinoids are THC (tetrahydrocannabinol) and CBD (cannabidiol). Cannabinoids have been shown to affect the endocannabinoid system within the human body, which is why CBD has demonstrated effectiveness as a therapeutic option when delivered through the right absorption avenues. The 2018 Farm Bill is expected to have a sustained impact on the growth of the cannabidiol market and related sectors. In 2018, the global cannabidiol market was valued at $4.6 billion, and it’s expected to increase almost sixfold by 2025, reaching $23.6 billion (https://ibn.fm/PL6PO). This growth is expected to provide multiple opportunities to CannAssist and its high-quality, high-performance brands, including products currently under development. Based on current revenue from licensing agreements, retail sales and the Xceptol brand’s international distribution, the company expects to reach first-year sales of $5 million. With additional products in the pipeline and an unwavering commitment to quality and effectiveness, the company expects to see steady sales growth in the years ahead. Xceptor Labs Xceptor Labs is an R&D and raw material manufacturing company that partners with TakaUSA, in Coppell, Texas, for contract manufacturing and production services. CiBiDinol Technology Xceptor Labs’ technology, CiBiDinol, is formulated using a proprietary process developed by CannAssist Founder Mark Palumbo. It is specifically designed to address many critical issues with oil-soluble CBD molecules, including delivery, bioavailability and short shelf-life. This technology provides the basis for Xceptor Labs and Xceptol consumer products. CiBiDinol is believed to provide CBD in a format that is more in line with the body’s natural bioactivity. The company’s proprietary processes are used to combine CBD molecules with penetration enhancing cyclodextrin, effectively modifying the CBD molecule’s surface and rendering it water dispersible. This technology enhances absorption through the skin and gut. The company believes that CBD products created using its CiBiDinol technology offer more predictable potency and enable reduced dosage requirements. This technology clears the way for a wide variety of products, including many oil-soluble active ingredients and highly effective consumer product applications. Independent Testing Third-party testing has confirmed that products made with CiBiDinol demonstrate a 400 percent increase in skin penetration as compared to regular CBD in oil carriers alone, as well as a 300 percent higher absorption rate in the gut. The company believes that the results indicate that the amount of CBD needed to achieve targeted endpoints can be significantly lower, resulting in lower costs for manufacturers and consumers with little to no side effects. “Oversight of manufacturing and third-party testing of this ingredient produced consumer products designed to provide clinicians and consumers safe, effective, and affordable treatment options to address their health and wellness concerns,” Palumbo said in a news release. CiBiDinol is currently being evaluated for safety by the National Science Foundation for Global Recognition and has been submitted to the FDA’s bulk drug substance program. The company is developing a commerce pathway in each state’s pharmaceutical distribution network through the National Board of Pharmacies. The company aims to capture increasing market share through product extensions and advancements by seeking critical third-party analysis and physician feedback regarding its proprietary technology’s attributes. Xceptor Labs intends to offer licensing arrangements for brand-consumer companies. Xceptol Products CiBiDinol technology is the foundation for Xceptor Labs and the Xceptol line of products, including topical creams, capsules, tinctures and pet drops. The Xceptol line began launching its products in September 2020, and it currently has five National Drug Code topical pain creams utilizing ingredients registered with the FDA. Xceptol products will be sold online, through Range Me, as well as through national and international retail and pharmaceutical distributors. Marketing for Xceptol products is planned through multiple social media campaigns including using celebrities and former athletes associated with Freedman Sports Promotional Relations. Xceptol is establishing sales channels in North America, Central America, South America, South Africa, the EU, the UK and the Philippines. Management Team Mark Palumbo, CEO and Founder, is an entrepreneur, scientist and executive with over 30 years in the health care, laboratory and manufacturing industries. His entrepreneurial endeavors include a successful personal care industry distribution company, a currently owned and operated tissue culture laboratory and Xceptor Labs, now part of CannAssist International. Marla Palumbo, President, is a health care professional and registered nurse with over 30 years of experience in the industry. She handles sales, patient advocacy, patient care and general management. Marla Palumbo has effectively developed and grown a personal care distribution company with significant year over year increases in sales. Her management and organization skills were instrumental in the early development of Xceptor Labs, leading to its CannAssist International public company status. Dr. Rahul Dixit, MD, Medical Director, is a doctor of gastroenterology at Providence St. John’s Medical Center in Santa Monica, California. He was part of a double fellowship with the University of Miami in Gastroenterology and Hepatology/Liver Transplant at Johns Hopkins Hospital. He has over 20 years of experience with cannabis and hemp-related products. Takako McGowan, Managing Director, Founding Member and Owner of TakaUSA, brings 40 years of experience in manufacturing and consumer product research & development to the CannAssist team. Camron Elizabeth, Managing Director-Sales and Marketing, is an entrepreneur and leader who has brought immense success to the companies with whom she has worked. As Founder and CEO of Platinum Pack, Elizabeth was responsible for all aspects of its success in bringing products from concept to completion and successful sell-through on the retailer’s shelf. She has been in the beauty industry for over 40 years. Benjamin Perlstein, VP of Operations, has been a part of the health care and business development field for over 25 years. As a surgical technologist, he has experience as a clinical application specialist and materials manager. Braden Traub, Director of Marketing and Customer Development, is an entrepreneur and business owner with 10 years of experience in the health and fitness industries. Traub also has skills and experience as a tax resolutionist and legal document preparer. For more information, visit the company’s website at www.CannAssistInternational.com. NOTE TO INVESTORS: The latest news and updates relating to CNSC are available in the company’s newsroom at https://ibn.fm/CNSC Safe Harbor for Forward-Looking Statements Forward-looking statements are inherently subject to risks and uncertainties which could cause actual results to differ materially from those in the forward-looking statements, including, without limitation, the following: the timing and nature of any capital raising transactions; the Company’s ability to offer products and services for use by customers in existing and new markets; the Company’s ability to deliver in a timely fashion and to its customers’ satisfaction the products purchased; the risk of competition; its ability to find, recruit and retain personnel with knowledge and experience in selling products and services in existing and new markets; its ability to manage growth; and general market, economic and business conditions. Additional factors that could cause actual results to differ materially from those anticipated by the Company’s forward-looking statements are under the captions “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in its Annual Report on Form 10-K for the fiscal year 2019 and its subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, all filed with the Securities and Exchange Commission. Forward-looking statements are made as of the date hereof, and the Company expressly disclaim any obligation or undertaking to update forward-looking statements.